Free Trial

Global X S&P Biotech ETF (CURE) News Today

Global X S&P Biotech ETF logo

CURE Latest News

Global X S&P 500 U.S. Market Leaders TOP 50 ETF
XBI: Biotech ETF Is A Must Have
Risky Loans Get the ETF Treatment
Defence's AccuTOX(R) Impairs Lung Cancer Growth
Biotechtech Stocks Find a Cure: M&A
These 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bank
Here's what to expect from Burning Rock Biotech's earnings report
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
5 Best Pharma ETFs
Krystal Biotech (KRYS) Receives a New Rating from Berenberg Bank
ETFs to Play Biotech M&A
Global X Launches 2 ESG-Focused Covered Call ETFs
7 Cheap But Risky Biotech Stocks
Global X S&P Biotech ETF (CURE.AX)
Get Global X S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CURE Media Mentions By Week

CURE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CURE
News Sentiment

0.00

0.54

Average

News Sentiment

CURE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CURE Articles
This Week

0

0

CURE Articles
Average Week

Get the Latest News and Ratings for CURE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Global X S&P Biotech ETF and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (ASX:CURE) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners